Review: TradeStops The Stock Genome Project


Stock Trend Alerts Reviews

Table of Contents

Just a Quick Intro

Keith Kaplan and TradeSmith have started a new promo campaign for their TradeStops investment and portfolio-analysis software called the Stock Genome Project.

Kaplan and his team have harnessed the power of their TradeStops software suite to offer “Wall Street caliber technology” to everyday investors.

Based on a powerful proprietary algorithm that makes millions of calculations every day, the TradeStops package includes tools designed to provide investors with concise, continually-updated stock recommendations.  

Keep reading if you want to learn more about Keith Kaplan, TradeStops, and their Stock Genome Project.

Who is Keith Kaplan?

Keith Kaplan is the CEO of TradeSmith, the investment research firm which developed and maintains the market analysis software known as TradeStops.

A software architect and engineer with decades of experience, Keith describes himself as someone good at making money but not so successful at investing it.  

All that changed when he encountered the team at TradeSmith in 2015. Using their “proprietary VQ algorithm,” Kaplan helped them develop the suite of trading and investment analysis software tools known as TradeStops.

Rising through the company ranks to become CEO, Keith developed a passion for sharing this software with other independent investors. The same software helped him “[turn his] own financial history around.

Keith Kaplan is the CEO of TradeSmith

What is TradeStops?

TradeStops is a software suite of investment and stock portfolio analysis tools developed by TradeSmith and its CEO, Keith Kaplan.

TradeSmith is known for its proprietary “VQ algorithm,” which is based on the work of Nobel Prize-winning economists and serves as the heart of the TradeStops software.

The TradeStops tools were created to provide investors with the detailed information needed to:  know when to enter or exit any investment position, know how many shares of a stock to buy, know the actual health of potential stock purchases, and know “at a glance”  the most up-to-date recommendations for their investments.

The latest update to this software is called the Stock Genome Project.

The Stock Genome Project

After millions of dollars and a decade spent in development, Keith Kaplan finally believes that his Stock Genome Project is ready for primetime.

Keith argues that just like every cell in our bodies, stocks contain a “unique genetic code” hidden deep within them.

For all intents and purposes, this code represents that stock’s “DNA.”

And, in much the same way doctors can now analyze our genetic information to reveal hidden diseases and weaknesses, Kaplan’s system scrubs through “stock DNA,” determining the relative “health” of each stock.

According to Kaplan:

“What we’ve uncovered is mind-blowing. Every stock has its own unique DNA! No two stocks are the same, just like no two people are the same.”

The team at TradeSmith claims to have used this information to “crush the performance of billionaire investors” and predict market trends days or even “weeks ahead of time.”

They’re calling the Stock Genome Project

“…the single greatest edge in the investing world.”


“…the biggest breakthrough in history for Main Street Americans.”

The system requires a ludicrously expensive supercomputer to crunch through millions of daily calculations for the stocks in its database.

The mathematical backbone of this constant, “genetic” analysis of tens of thousands of different stocks, day in and day out, is the Volatility Quotient Signal algorithm.

Stock DNA and the Volatility Quotient Signal

Simply put, the Volatility Quotient (VQ) Signal (or score) is a number that tells investors how a stock is expected to behave.

This VQ score is the key to understanding the DNA of any given stock. It’s the “secret ingredient” that powers the Stock Genome Project.

As TradeSmith describes it, every stock has its own unique VQ score. Volatile stocks have a high VQ score, and more stable stocks have a low VQ score.

By comparing the current behavior of a stock to its VQ score, TradeSmith claims that its system can determine if the trading activity seems normal or if something more unusual is afoot.  

This “genetic” scan of a company’s VQ signal, which requires 9,250 calculations per day” for each stock, provides investors with real-time information to help grow and protect their portfolios.

The VQ signal is designed to remove the human factor from the investing equation. 

This frees investors to make decisions based on numbers rather than emotions.  

To know when to buy…  

…And to recognize when the instinct to dig in your heels on a tanking stock is driven by stubbornness rather than cold, hard facts.

For investors who’ve followed past recommendations of TradeStops’  VQ-powered Stock DNA, Kaplan cites potential returns of:

  • 259% on Immunovant
  • 308% on Nine Energy Service Inc.
  • 1,040% on Tesla
  • 1,887% on Novavax
  • 4,628% on GameStop

Not too shabby.

So, now you may be asking…

How Exactly Does TradeStops Work?

Keith’s been asked more than once to explain precisely what’s “going on under the hood” of this thing.

The TradeStops software platform includes several tools designed to help subscribers take advantage of the continually-updated VQ signal information.

First, the software analyzes over 50,000 securities, including stocks, mutual funds, index funds, and ETFs.  

Subscribers get full access to this Stock Genome Project DNA Database.

Second, there is the DNA Health Status ticker which translates the VQ score of every stock into a simple recommendation system modeled after a stoplight.

  • RED:  Sell
  • YELLOW:  Hold or Caution
  • GREEN:  Buy

And time durations are listed to show investors exactly when the status of each stock changed.

Third, brokerage account connection functionality is built into the software, allowing users to link their investment portfolios and get instant, completely private scores for every security they own.  

This means subscribers receive constantly-updated DNA reports indicating the health of each of their holdings.  

And TradeSmith ensures that their users’ portfolio data is protected by “airtight, bank-level security.”

Fourth, the software includes extensive newsletter connection functionality. This means you can link the model portfolios of any major financial publications to which you subscribe…and instantly see the comprehensive DNA and health ratings for those stocks.

Fifth, TradeStops includes a position size calculator which shows users their predicted risk for any dollar amount they wish to invest in any given stock.

This means users can calculate their ideal position size on any stock…  

…And see whether it’s time to buy or sell shares based on the latest health score for that company.

And last but not least

TradeStops includes an entirely customizable, automatic alert system to keep users up-to-date on any changes in the health status of their holdings.

You set the criteria for what triggers an alert for each stock and individual position, so Kaplan promises you’ll always have the info you need without having to stay “glued to your screen.”

What’s Included with a Subscription to TradeStops?

Memberships to TradeStops provide access to their suite of market and portfolio analysis tools.

Here’s what you get when you subscribe during the Stock Genome Project promotional period:

  • An 85% discount off the standard membership price.
  • Constantly-updated Volatility Quotient scores for the 50,000+ different securities in the Stock Genome Project Database.
  • Full access to the VQ-based “stoplight alert system” that gives you instant buy/hold/sell alerts on every stock in the database.
  • Instant, private analysis of your own portfolio data provided with “bank-level” security.
  • Instant risk and position sizing data on any stock ticker symbol you want to see, telling you how many shares to buy and the risk involved.
  • Access to the newsletter center, allowing you to link to the model portfolios of your preferred financial publications.
  • Customizable alerts to let you know whenever a buy, sell, or hold is issued on one of your stocks.
  • Access to a series of video tutorials for new users.
  • The opportunity to book a private, one-hour appointment with a TradeSmith concierge should you need any additional assistance.

BONUS REPORT – The Stock Genome Project: How to 10X Your Portfolio With Stock DNA

This hot-off-the-presses report serves as a quick start guide to harnessing the power of the TradeStops software suite.

It contains all the basics required to jump straight into the deep end with TradeStops’ Stock DNA tools, as well as a “peek behind the scenes at how [the] software works.”

How Much is TradeStops? 

Subscriptions to the service are usually priced at $588 per year. 

The current Stock Genome Project promotion entices new subscribers with a heavily discounted rate of $79 for the first year.

This is a savings of over 85% off the standard access fee.

TradeSmith does offer the TradeStops software at three different subscription tiers during this promo:  Basic, Plus, and Premium.

The $79 promotional rate listed is for the mid-level Plus subscription tier.

The Basic tier is currently priced at $49 (normally $228), but it truly lives up to its name and lacks most of the features described above.

The Premium tier presently runs $129 (usually $999) and includes everything offered at the Plus level, as well as three additional software tools targeted at advanced users:

  • Portfolio Volatility Quotient (PVQ) Analyzer
  • Risk Rebalancer Tool
  • Asset Allocation Tool

If you’re just getting your feet wet using stock analysis software such as TradeStops, the $79 Plus tier looks like it offers the most bang for your buck.

If this isn’t your first rodeo, the Premium tier may be worth a serious once-over.

TradeStops Pricing

TradeStops Refund Policy

TradeStops Plus offers new subscribers an “ironclad” 60-day, 100% money-back guarantee.

No muss. No fuss.

TradeStops Refund Policy

Where to Find TradeStops

TradeStops is an investment risk-management and portfolio analysis software suite produced by Keith Kaplan and his team at TradeSmith.  

The company’s stated mission is to provide individual investors with the tools and knowledge needed to “outperform the markets.

Go HERE to learn more about TradeStops and Keith Kaplan’s team at TradeSmith.

In Summary

TradeSmith is currently running a new promo campaign for TradeStops called the Stock Genome Project.

After more than a decade of research, CEO Keith Kaplan and his team claim to have developed the perfect market analysis software for deep-diving into the fundamentals of any stock.

Based on the TradeStops platform, they call it the Stock Genome Project.  

Kaplan equates it to seeing the DNA of that stock.  

Powered by TradeSmith’s proprietary VQ algorithm, the TradeStops software package includes several tools designed to help investors avoid rash, emotion-driven mistakes.  

These tools include a Stock Genome Project DNA Database of 50,000 different securities, a VQ-powered stock health ticker, analysis of user portfolio data, a position sizing calculator, financial newsletter portfolio analysis, and customizable stock alerts.

New subscribers are eligible for 85% off their first-year subscription rate during the promotional period.

To learn more about Keith Kaplan and TradeSmith, or to subscribe to TradeStops today, visit the official website. 

You Might Also Like...